Across the United States, one in every 10 babies is born premature (before 37 weeks gestation). In Louisiana, that number is even higher with a 13 percent preterm birth rate, making it the second-highest state in the country for pre-term births, behind Mississippi. Since access to high-quality prenatal care both for mother and baby has been shown to increase the chances of a safer, full-term pregnancy, Ochsner Health System is offering a Maternal Fetal Medicine (MFM) Fellowship to train the next generation of healthcare professionals in this high-demand specialty.
Mardi Gras revelers can indulge in the season’s most beloved sweet treat without busting their New Year’s resolutions, thanks to the Eat Fit King Cake. On sale in select stores throughout Louisiana and Texas and available for purchase online, the Eat Fit King Cake is gluten free, grain free, low carb, sugar-free, dairy free, and all natural, without sacrificing flavor.
The Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health has awarded Chosen Diagnostics Inc, a spin-out company, a $299,641 Phase I Small Business Technology Transfer award. Based on an LSU Health New Orleans research breakthrough, the award will advance the development and commercialization of a noninvasive diagnostic biomarker test for necrotizing enterocolitis invented by Sunyoung Kim, PhD, professor of biochemistry and molecular biology at LSU Health New Orleans School of Medicine. The principal investigator for the grant
Thibodaux Regional Health System announced that it was among a select group of hospitals nationwide recognized for promoting enrollment in state organ donor registries in a national campaign sponsored by the U.S. Department of Health and Human Services’ Health Resources and Services Administration (HRSA).
A Tulane University researcher has received a grant that will support the development of new imaging methods to improve the treatment of preeclampsia.
Carolyn Bayer, an assistant professor of biomedical engineering, said the five-year $1.57 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development will enable her and her team to better determine the impact of specific drugs in the treatment of preeclampsia